Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients

被引:173
作者
Hamanishi, T
Furuta, H
Kato, H
Doi, A
Tamai, M
Shimomura, H
Sakagashira, S
Nishi, M
Sasaki, H
Sanke, T
Nanjo, K
机构
[1] Wakayama Univ Med Sci, Dept Med 1, Wakayama 6418509, Japan
[2] Wakayama Univ Med Sci, Dept Clin Lab Med, Wakayama 6418509, Japan
关键词
D O I
10.2337/diabetes.53.9.2455
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis in type 2 diabetic patients has been linked to increased oxidative stress. Glutathione peroxidase-1 (GPx-1) plays an important role in the antioxidant defense of the vascular wall. To assess the association between variants in the GPx-1 gene and atherosclerosis, we screened the gene in 184 Japanese type 2 diabetic patients and identified four polymorphisms (-602A/G, +2C/T, Ala(5)/Ala(6), and Pro198Leu). Among these polymorphisirns, -602G, +2T, Ala(6), and 198Leu were in strong linkage disequilibrium with each other. The patients were divided into two groups on the basis of the codon 198 polymorphism, Pro/Pro (n=151) and Pro/Leu (n=33), to analyze clinical characteristics. The mean intima-media thickness (IMT) of common carotid arteries (P=0.0028) and the prevalence of cardiovascular disease (P=0.035) and peripheral vascular disease (P=0.027) were significantly higher in the Pro/Leu group than in the Pro/Pro group. In vitro functional analyses indicated that the combination of polymorphisms (Ala(6)/198Leu) of the GPx-1 gene had a 40% decrease in enzyme activity, and the combination of polymorphisms (-602G/+2T) had a 25% decrease in transcriptional activity. These results suggest that functional variants in the GPx-1 gene are associated with increased IMT of carotid arteries and risk of cardiovascular and peripheral vascular diseases in type 2 diabetic patients.
引用
收藏
页码:2455 / 2460
页数:6
相关论文
共 27 条
[1]  
Andersen HR, 1997, CLIN CHEM, V43, P562
[2]  
Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825
[3]   Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part I [J].
Creager, MA ;
Lüscher, TF ;
Cosentino, F ;
Beckman, JA .
CIRCULATION, 2003, 108 (12) :1527-1532
[4]   Heterozygous cellular glutathione peroxidase deficiency in the mouse - Abnormalities in vascular and cardiac function and structure [J].
Forgione, MA ;
Cap, A ;
Liao, R ;
Moldovan, NI ;
Eberhardt, RT ;
Lim, CC ;
Jones, J ;
Goldschmidt-Clermont, PJ ;
Loscalzo, J .
CIRCULATION, 2002, 106 (09) :1154-1158
[5]   Cellular glutathione peroxidase deficiency and endothelial dysfunction [J].
Forgione, MA ;
Weiss, N ;
Heydrick, S ;
Cap, A ;
Klings, ES ;
Bierl, C ;
Eberhardt, RT ;
Farber, HW ;
Loscalzo, J .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (04) :H1255-H1261
[6]   Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1 [J].
Forsberg, L ;
de Faire, U ;
Marklund, SL ;
Andersson, PM ;
Stegmayr, B ;
Morgenstern, R .
BLOOD CELLS MOLECULES AND DISEASES, 2000, 26 (05) :423-426
[7]  
Hink U, 2001, CIRC RES, V88, pE14
[8]   NUCLEOTIDE-SEQUENCE OF A HUMAN-GENE FOR GLUTATHIONE-PEROXIDASE [J].
ISHIDA, K ;
MORINO, T ;
TAKAGI, K ;
SUKENAGA, Y .
NUCLEIC ACIDS RESEARCH, 1987, 15 (23) :10051-10051
[9]   Assignment of the ARHA and GPX1 genes to human chromosome bands 3p21.3 by in situ hybridization and with somatic cell hybrids [J].
Kiss, C ;
Li, J ;
Szeles, A ;
Gizatullin, RZ ;
Kashuba, VI ;
Lushnikova, T ;
Protopopov, AI ;
Kelve, M ;
Kiss, H ;
Kholodnyuk, ID ;
Imreh, S ;
Klein, G ;
Zabarovsky, ER .
CYTOGENETICS AND CELL GENETICS, 1997, 79 (3-4) :228-230
[10]  
Kobayashi Seiichi, 2002, J Atheroscler Thromb, V9, P184